Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04041336
Other study ID # 19006
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date September 3, 2019
Est. completion date October 1, 2020

Study information

Verified date May 2022
Source University of Nottingham
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Assessment of the feasibility of achieving retinal imaging in older people with recent hips fracture surgery using hand held optical coherence tomography device


Description:

Optical coherent tomography (OCT) is a device used to achieve cross-sectional imaging of tissues. It is often used in ophthalmology and also has application in dermatology, cardiology and other specialities. Usually, in adults, a table-top device is used necessitating the transfer of patients to the location of the device. In children a hand held device is used meaning the device can be taken to the patients' location. To facilitate/ help design a future study, this study's aim is to assess the feasibility of achieving retinal imaging in older people who are recovering from hip fracture surgery using a hand held device.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date October 1, 2020
Est. primary completion date October 1, 2020
Accepts healthy volunteers No
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Recent hip fracture surgery - Age > 64 years - No cognitive impairment - Able to understand instructions given in English - Consent Exclusion Criteria: - Presence of degenerative eye disease e.g. age-related macula degeneration, glaucoma, diabetic retinopathy, hypertensive retinopathy - Dementia, mild cognitive impairment, Parkinson,s disease, multiple sclerosis, current delirium

Study Design


Related Conditions & MeSH terms


Intervention

Diagnostic Test:
Optical coherence tomography
Non-invasive method of acquiring cross sectional imaging of tissues using the coherent property of light

Locations

Country Name City State
United Kingdom Queen's Medical Centre Nottingham Nottinghamshire

Sponsors (1)

Lead Sponsor Collaborator
University of Nottingham

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ability to achieve good quality retinal images Retinal images with signal strength > 6 and in which retinal layers can be measured 30 minutes
Primary Ability to achieve imaging without causing pain Patient reported pain during acquisition of images over their baseline. Scale of 0 - 10 where 0 is no increase in pain and 10 is severe increase in pain Immediate
See also
  Status Clinical Trial Phase
Withdrawn NCT03037268 - Quality and Diagnostic Utility of Mydriatic Fundus Plenoptic Photography
Completed NCT05608265 - Real-time Eye Tracking and Imaging of the Eye in Diabetic Retinopathy Patients N/A
Active, not recruiting NCT04116814 - High Resolution Imaging of Retinal Vessels as a Biomarker of Cardiovascular Disease in Patients With Renal Insufficiency - RI